In South Africa, we are engaged in the sale and distribution of generic prescription products in the healthcare market. We are ranked No. 6 amongst generic companies. Additionally, we offer high quality, affordable Anti-retrovirals (ARVs) to patients in Africa, supporting governments in their efforts to control HIV/AIDS.
At a Glance
Launched Operations: 1996
No. of Molecules: 99
Leading Molecules: Levofloxacin, Cefpodoxime Proxetil, Clarithromycin, Atorvastatin, Co-amoxiclav, Paracetamol, Amoxicillin, Topiramate, Prednisone, Cilastatin & Imipenem, Tripolodine, Cefuroxime Axetil, Fluconazole, Sertraline, Diphenhydramine, Chlorampheneramine, Ibuprofen, Simvastatin, Ranitidine
Presence in Therapeutic Segments: Anti-infectives, Central Nervous System (CNS), Cardiovascular, Over-the-Counter (OTC), Pain management, Gastrointestinal, Cough & Cold, Anti-histamines, Anti-retrovirals (ARVs)
CEO-Ranbaxy (S.A) (PTY) Limited & Be-Tabs Pharmaceuticals (PTY) Limited
RANBAXY (S.A) (PTY) LIMITED
BE-TABS PHARMACEUTICALS (PTY) LTD.
Riverside Office Park,
1303 Heuwel Avenue,
|+ 270 -126 4320 00|
|+ 270 -126 432 001/3|
Lautre Road 3,
Disclaimer: Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement.
The products listed in this page are meant only of the specific country(ies) mentioned in this page and not for any other market or country.